UK Plasmid Dna Manufacturing Market Size & Outlook
UK plasmid dna manufacturing market, 2018-2030 (US$M)
Related Markets
UK plasmid dna manufacturing market highlights
- The UK plasmid dna manufacturing market generated a revenue of USD 123.6 million in 2023 and is expected to reach USD 503.9 million by 2030.
- The UK market is expected to grow at a CAGR of 22.2% from 2024 to 2030.
- In terms of segment, gmp grade was the largest revenue generating grade in 2023.
- GMP Grade is the most lucrative grade segment registering the fastest growth during the forecast period.
Plasmid dna manufacturing market data book summary
| Market revenue in 2023 | USD 123.6 million |
| Market revenue in 2030 | USD 503.9 million |
| Growth rate | 22.2% (CAGR from 2023 to 2030) |
| Largest segment | Gmp grade |
| Fastest growing segment | GMP Grade |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | R&D Grade, GMP Grade |
| Key market players worldwide | Charles River Laboratories International Inc, Danaher Corp, Kaneka Corp, Eurofins Scientific SE, Lonza Group Ltd, Akron Biotechnology, Luminous BioSciences, Lonza Group Ltd ADR, Cell & Gene Therapy, Nature Technology, VGXI |
Other key industry trends
- In terms of revenue, UK accounted for 6.8% of the global plasmid dna manufacturing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK plasmid dna manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 243.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Plasmid DNA Manufacturing Market Scope
Plasmid DNA Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK plasmid dna manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasmid dna manufacturing market will help companies and investors design strategic landscapes.
Gmp grade was the largest segment with a revenue share of 86.08% in 2023. Horizon Databook has segmented the UK plasmid dna manufacturing market based on r&d grade, gmp grade covering the revenue growth of each sub-segment from 2018 to 2030.
In the UK, nearly 155,000 people aged 70 and above are estimated to be diagnosed with cancer every year, which represents 50% of all cancer diagnoses. This percentage is likely to increase with the growing geriatric population.
The rising need for cancer management is anticipated to fuel market growth by encouraging companies to develop robust cancer therapies. According to a 2019 survey conducted by the Cell and Gene Therapy Catapult, UK, there were 26 MIA and MHRA MIA (IMP) licensed gene & cell therapy manufacturing facilities in the UK.
Moreover, there were two licensed commercial production (MIA) facilities in the country as of November 2019. This wellestablished facility network coupled with a strong workforce is anticipated to fuel market growth. In recent years, the country witnessed significant growth in the commercial sector.
Reasons to subscribe to UK plasmid dna manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK plasmid dna manufacturing market databook
-
Our clientele includes a mix of plasmid dna manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK plasmid dna manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into UK plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK plasmid dna manufacturing market size, by grade, 2018-2030 (US$M)
UK Plasmid DNA Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
